“I’m excited,” Beth Shapiro, Colossal’s chief science officer, told PEOPLE in an exclusive interview in March. She described ...
The Colossal Foundation, the nonprofit arm of Colossal Biosciences, has just secured an additional $50 million in funding.
Dallas biotech startup Colossal just got a little more sci-fi. The company behind efforts to de-extinct the woolly mammoth and other long gone species announced Tuesday its acquisition of Viagen, an ...
A biotech company says it has bred three animals with key physical features of the dire wolf — a species that has been extinct for more than 12,000 years. Colossal Biosciences says it used novel ...
The Dallas company working to bring back the woolly mammoth just doubled its nonprofit funding to $100 million. Find out ...
Biotechnology company Colossal Biosciences used genetic editing techniques to alter 20 genes of gray wolves (pictured above) to express certain characteristics of ancient dire wolves. The company says ...